Glaxo's diabetes drug beats older rivals
Diabetes mellitus is a medical disorder characterized by varying or persistent hyperglycemia (elevated blood sugar levels), especially after eating. Hyperglycemia itself can lead to dehydration and ketoacidosis. Longer-term complications include cardiovascular disease (doubled risk), chronic renal failure, retinal damage with eventual blindness, nerve damage, etc.
Glaxo's diabetes drug beats older rivals

Diabetes :: Glaxo's diabetes drug beats older rivals
Diabetes patients starting out on GlaxoSmithKline drug Avandia have a better chance of keeping blood sugar levels within safe limits than those given older medicines, revealed after a clinical trial by Glaxo.
A clinical trial tracking patients for up to five years found the right medicines could slow the progress of type 2 diabetes significantly, holding out the prospect of better treatment.
Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with Avandia? (rosiglitazone maleate) reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin (p<0.001), and 63 percent compared to glyburide (p<0.001) at five years.
The results of this international study involving 4,360 people recently diagnosed with type 2 diabetes were today published in the New England Journal of Medicine and presented at the 19th World Diabetes Congress of the International Diabetes Federation (IDF).
(
Diabetes :: Glaxo's diabetes drug beats older rivals published at
SpiritIndia on Tuesday, December 5, 2006)
Search more information on
DiabetesRecently posted related articles on Diabetes :
- Diabetes :: 63 percent of diabetics risk serious foot problems by wearing the wrong-sized shoes
- Diabetes :: India to launch special programme to control diabetes
- Diabetes :: Stanford researchers shed light on gestational diabetes
- Diabetes :: The new source of islet cells
- Diabetes :: European Medicine Agency confirms positive Avandia benefit risk assessment
- Pancreatitis :: Diabetes drug Byetta, exenatide may cause acute pancreatitis
- Diabetes :: PGC-1-alpha helps skeletal muscle and pancreatic islets communicate
- Blood Pressure :: Women with high or increasing blood pressure are up to three times more likely to develop diabetes
- Diabetes :: New IDF guidelines raise importance of post-meal glucose control
- Diabetes :: Solving a critical part of the insulin puzzle
»»
Rich :: Richest 2 percent own half world wealth««
NHS :: NHS Plan for A&E cutsThe information provided on
SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information.
Health,
Business,
Science,
Sports,
Entertainment,
Technology
©2002-2009 SpiritIndia.com